tyrosyl-seryl(o-tert-butyl)-glycyl-phenylalanyl-leucyl-threonine has been researched along with norbinaltorphimine in 1 studies
| Studies (tyrosyl-seryl(o-tert-butyl)-glycyl-phenylalanyl-leucyl-threonine) | Trials (tyrosyl-seryl(o-tert-butyl)-glycyl-phenylalanyl-leucyl-threonine) | Recent Studies (post-2010) (tyrosyl-seryl(o-tert-butyl)-glycyl-phenylalanyl-leucyl-threonine) | Studies (norbinaltorphimine) | Trials (norbinaltorphimine) | Recent Studies (post-2010) (norbinaltorphimine) |
|---|---|---|---|---|---|
| 25 | 0 | 0 | 918 | 0 | 205 |
| Protein | Taxonomy | tyrosyl-seryl(o-tert-butyl)-glycyl-phenylalanyl-leucyl-threonine (IC50) | norbinaltorphimine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.0104 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.0029 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.212 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.024 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.0036 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mulder, AH; Ronken, E; Schoffelmeer, AN | 1 |
1 other study(ies) available for tyrosyl-seryl(o-tert-butyl)-glycyl-phenylalanyl-leucyl-threonine and norbinaltorphimine
| Article | Year |
|---|---|
Interacting presynaptic kappa-opioid and GABAA receptors modulate dopamine release from rat striatal synaptosomes.
Topics: Analysis of Variance; Animals; Benzeneacetamides; Bicuculline; Corpus Striatum; Dopamine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; gamma-Aminobutyric Acid; Kinetics; Male; Naltrexone; Narcotics; Oligopeptides; Picrotoxin; Potassium; Pyrrolidines; Rats; Rats, Wistar; Receptors, GABA-A; Receptors, Opioid, kappa; Synaptosomes | 1993 |